BDX06.BK Becton, Dickinson and Company
- Market cap
- -
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- 28.00%
- Fundamental score
- -
Is BDX06.BK undervalued?
Graham numberThe Graham number of Becton, Dickinson and Company cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Becton, Dickinson and Company fundamental analysis
No fundamental analysis for Becton, Dickinson and Company yet.
Becton, Dickinson and Company stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Becton, Dickinson and Company
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, …
Full company profileFinancial statements of Becton, Dickinson and Company are not available yet.
Becton, Dickinson and Company dividends
Becton, Dickinson and Company has not paid dividends in the last 4 fiscal years.
Who owns Becton, Dickinson and Company
Ownership data of Becton, Dickinson and Company is not available yet.
Becton, Dickinson and Company company profile
- Company name
- Becton, Dickinson and Company
- Ticker
- BDX06.BK
- Exchange
- Thailand Exchange
- Sector
- -
- Industry
- -
- Employees
- 60,000
- Fiscal year end
- September
- Address
- 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880
- Phone
- 201 847 6800
- Website
- bd.com
About Becton, Dickinson and Company
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Becton, Dickinson and Company management
10- Mr. Thomas E. Polen Jr.President, CEO & Chairman · born 1973
- Mr. Michael C. FeldExecutive VP & Chief Revenue Officer · born 1981
- Mr. Vitor RoqueExecutive VP & CFO · born 1983
- Ms. Elizabeth McCombsExecutive VP & CTO · born 1977
- Dr. Joseph M. Smith F.A.C.C, M.D., Ph.D.Senior VP & Chief Scientific Officer
- Mr. Arthur HuExecutive VP and Chief Information & Digital Officer
- Mr. Shawn C. BevecSenior Vice President of Investor Relations
- Ms. Lanesha T. Minnix J.D.Executive VP & General Counsel · born 1975
- Carla BurigattoSenior VP & Chief Communications Officer
- Ms. Meera GopalakrishnanSenior VP & Global Chief Marketing Officer